MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Common gene disorder doubles risk of lung cancer

Back to lung cancer blog Blogs list Cancer blog  


Subscribe To Lung Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Common gene disorder doubles risk of lung cancer




Mayo Clinic scientists have observed that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.

The study is reported in the May 26 issue of the Archives of Internal Medicine, a journal published by the American Medical Association.

Scientists observed that the genetic disorder, alpha-1 antitrypsin deficiency (1ATD), could explain up to about 12 percent of patients with lung cancer in this study and likely represents the same widespread risk in the general population. "This is a seriously underdiagnosed disorder and suggests that people who have lung cancer and chronic obstructive pulmonary diseases (COPD) in their families should be screened for these gene carriers," says Ping Yang, M.D., Ph.D., a Mayo Clinic epidemiologist and lead investigator on the study.



Common gene disorder doubles risk of lung cancer

The current standard diagnostic test measures protein produced by the gene. Because of the cost and limited availability of the test, it's not suitable for general screenings. A less expensive DNA-based gene panel test is being developed.

The World Health Organization estimates that at least 10 million Americans and 120 million people worldwide are 1ATD carriers. As per Dr. Yang, this study shows that the disorder "is among the highest for major gene effects on the risk of a common cancer."

A normal 1AT gene produces a protein that stops enzymes from breaking down elastin, which keeps lung tissue elastic for normal function. Carriers of 1ATD usually develop emphysema and/or chronic obstructive pulmonary disease (COPD). Previous to this study, the correlation between 1ATD, COPD and lung cancer risk had not been established.

"It has been suspected that 1ATD increased susceptibility to lung cancer," says Dr. Yang, "but this is the first solid evidence that supports and quantifies this risk.

"Importantly, our results support the hypothesis that the excess risk of lung cancer among patients with COPD may be a result of lung tissue damage from emphysema, or chronic infection or inflammation of the lungs, or both," she says.

Individuals who are 1ATD carriers should have lung function checked on a routine basis and should avoid potential lung carcinogens. "We found people who carry these genes are more vulnerable to carcinogen-containing tobacco smoke, even secondhand smoke, than noncarriers," says Dr. Yang.

In this study, a team of 12 scientists looked at three different groups: 1,443 lung cancer patients treated at Mayo Clinic from 1997 to 2003; a control group of 797 residents in the community; and a second control group of 902 siblings of the patients with lung cancer.

They observed that:

The 1ATD carrier rate among 1,443 genotyped lung cancer patients was 13.4 percent, in comparison to 7.8 percent among unrelated control participants.

All 1ATD gene carriers were at a similarly greater risk of developing lung cancer, regardless of smoking status. Those who had never smoked were at a 2.2-fold higher risk; light smokers had a twofold greater risk; and moderate to heavy smokers had a 2.3-fold increased risk. Eventhough there's no absolute definition, less than 20 pack-years of smoking cigarettes is defined as light; more than 40 pack-years as heavy. A pack-year is the number of packs of cigarettes smoked per day multiplied by the number of years the person has smoked.

A history of COPD increased lung cancer risk significantly for light, moderate and heavy smokers, but affected those who had never smoked the most X an almost sixfold increased risk.

Increased lung cancer risk among 1ATD carriers is independent of a family history of lung or other cancers.

The estimated attributable risk for 1ATD carriers in this study among those who never smoked and among heavy smokers was 11 percent to 12 percent, suggesting that the genetic disorder might explain a significant proportion of lung cancer in the general population. The majority of study participants were of European descent, the population in which this genetic disorder is common.

Eventhough the study helps explain why people who have never smoked can develop lung cancer, it doesn't mean that people who don't have the gene won't develop lung cancer, says Dr. Yang. "Smoking remains the overwhelming risk factor for lung cancer development".


Posted by: Scott    Source




Did you know?
Mayo Clinic scientists have observed that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers. The study is reported in the May 26 issue of the Archives of Internal Medicine, a journal published by the American Medical Association.

Medicineworld.org: Common gene disorder doubles risk of lung cancer

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.